Related Experiment Video
Updated: Jun 25, 2026
10:32
Assessing Functional Performance in the Mdx Mouse Model
Published on: March 27, 2014
Muscle genome-wide expression profiling during disease evolution in mdx mice
Mario Marotta1, Claudia Ruiz-Roig, Yaris Sarria
1Laboratori de Neurologia Infantil, Institut de Recerca, Barcelona, Spain. mmarotta@ir.vhebron.net
Physiological Genomics
|February 19, 2009
Summary
Mdx mice, a model for Duchenne muscular dystrophy, show altered gene expression, particularly in inflammation and muscle repair pathways. These findings reveal potential therapeutic targets for Duchenne patients.
Area of Science:
- Biochemistry
- Genetics
- Molecular Biology
Background:
- Duchenne muscular dystrophy (DMD) is a severe genetic disorder characterized by progressive muscle degeneration.
- Mdx mice, while sharing the genetic defect of DMD, exhibit a milder disease phenotype, suggesting compensatory mechanisms.
- Understanding these differences is crucial for developing effective therapies for DMD.
Purpose of the Study:
- To identify differentially expressed genes in mdx mice during disease progression.
- To elucidate the molecular mechanisms underlying the milder phenotype in mdx mice compared to DMD patients.
- To discover potential therapeutic targets for DMD.
Main Methods:
- Genome-wide microarray analysis of mdx and control mice at multiple time points (3 wk, 1.5 mo, 3 mo).
- Comparative gene expression analysis between mdx and control groups, and across different time points.
- RT-PCR validation of candidate gene expression.
- Functional network analysis to identify key gene subnetworks.
Main Results:
- Significant upregulation of inflammation-related genes (96%) and genes involved in cell adhesion, muscle structure/regeneration, and extracellular matrix remodeling (>75%) in mdx mice.
- Identification of key genes with strong variations: Lgals3, Postn, Ctss, Sln, Ecm1, Spon1, Thbs1, Csrp3, Myo10, Pde4b, and Adamts-5.
- Functional network analysis revealed two main subnetworks linked to dystrophin (Dmd) and extracellular matrix remodeling, involving genes like Utrn, Myo10, Adamts5, Thbs1, Spon1, and Postn.
Conclusions:
- Differential gene expression in mdx mice highlights compensatory mechanisms against muscle necrosis.
- Candidate genes identified may play a role in mitigating disease severity in mdx mice.
- These genes represent potential therapeutic targets for Duchenne muscular dystrophy.
